Maroof Hamidreza, Salajegheh Ali, Smith Robert Anthony, Lam Alfred King-Yin
Head of Pathology, Griffith Medical School, Gold Coast Campus, Gold Coast QLD 4222, Australia.
Curr Cancer Drug Targets. 2014;14(8):737-51. doi: 10.2174/1568009614666141020100337.
Altered expression of the microRNA-34 family has been determined to be involved in the pathogenesis of many cancers. In this review, the current knowledge of the cancer-related mechanisms in relation to the modulatory effects of microRNA-34 family were analysed. Expression analysis of the microRNA-34 family has suggested that its members play significant roles in many aspects of cancer biology including proliferation, invasion/metastasis, apoptosis/cell survival, cell cycle/cell growth, migration, senescence/aging, angiogenesis, epigenetic silencing and methylation by regulation of the expression of their target genes. Thus, microRNA-34 family members could act as prognostic markers and therapeutic targets in human cancers.
已确定微小RNA - 34家族的表达改变与许多癌症的发病机制有关。在本综述中,分析了与微小RNA - 34家族调节作用相关的癌症相关机制的现有知识。微小RNA - 34家族的表达分析表明,其成员在癌症生物学的许多方面发挥着重要作用,包括增殖、侵袭/转移、凋亡/细胞存活、细胞周期/细胞生长、迁移、衰老/老化、血管生成、表观遗传沉默和通过调节其靶基因的表达进行甲基化。因此,微小RNA - 34家族成员可作为人类癌症的预后标志物和治疗靶点。